In lieu of World TB Day, Eli Lilly and Co. (NYSE: LLY) has announced its plans to invest an additional $50 million in an innovative, global partnership to fight Multi-Drug Resistant Tuberculosis (MDR-TB).
According to Sidney Taurel, Lilly's chairman and chief executive officer:
"Eli Lilly and Company understands its role in the global battle against MDR-TB and recognizes its responsibility to those afflicted by this deadly disease. These additional funds will extend our commitment to transferring the technologies and improving the support systems needed to stop the spread of MDR-TB."
The Lilly MDR-TB Partnership is an international alliance of 14 public and private organizations (businesses, humanitarian organizations, academic institutions, and professional health care associations).
Find more details from the full report.
Comment Preview